RecruitingNCT06615661

A Real-World Evidence Study of Goniotomy With the C-REX™ Instrument in Patients With Primary Open Angle Glaucoma

An Observational Real-World Evidence Study of Ab-Interno Goniotomy Performed Using the C-Rex Instrument in Patients With Primary Open Angle Glaucoma


Sponsor

Iantrek, Inc.

Enrollment

200 participants

Start Date

Aug 14, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study enrolls adults with primary open angle glaucoma (POAG) who underwent goniotomy intraocular pressure (IOP)-lowering surgery with the C-Rex Instrument. Patients are consented prior to surgery and followed for 12 months postoperatively. Data regarding IOP, use of glaucoma medications, and any device-related complications are collected during the study time period.


Eligibility

Min Age: 22 Years

Inclusion Criteria2

  • Primary open angle glaucoma
  • Goniotomy surgery performed using the C-Rex Instrument

Exclusion Criteria4

  • History of intraocular surgery within 8 weeks prior to C-Rex surgery
  • Preoperative IOP higher than 33 mmHg
  • Presence of a glaucoma type other than POAG
  • Presence of clinically significant intraocular pathology other than cataract or glaucoma

Interventions

DEVICEC-Rex Instrument

The C-Rex Instrument is a manual ophthalmic surgical instrument used for ab interno goniotomy and inner wall trabeculotomy.


Locations(2)

Omni Eye Services

Atlanta, Georgia, United States

CIRCLE Site 04

Crossville, Tennessee, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06615661


Related Trials